SUMMARY A systematic prospective survey of 100 outpatients with rheumatoid arthritis revealed that 45 had biochemical evidence of liver disease. In most cases this was due to increases in total serum alkaline phosphatase (ALP) and/or gammaglutamyl transpeptidase (GGT). Examination of serum ALP isoenzyme profiles in 50 of the patients showed that the liver isoenzyme was the sole or major component in 44 patients, including many with normal total ALP levels. 180% had raised serum liver ALP together with raised GGT, suggestive of an underlying hepatobiliary lesion. No correlation could be detected between raised serum levels of liver enzymes and the age or sex of the patient, duration or severity of arthritis, and drug or alcohol history. However, there was a significant correlation between raised serum ALP and lacrimal or salivary gland dysfunction. It is suggested that immunological mechanisms may be involved in the development of hepatic abnormalities in rheumatoid arthritis.
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The association of rheumatic disorders with liver disease is well known but poorly understood. Overt clinical evidence of liver disease in uncomplicated rheumatoid arthritis is considered to be uncommon, although hepatomegaly has been reported in up to 20 % of patients (Webb et al., 1975; Tiger et al., 1976) . Abnormalities in the biochemical tests of liver function are more frequent, with elevated serum alkaline phosphatase levels being found in up to 50% of rheumatoid arthritis patients (Lefkovits and Farrow, 1955; Cockel et al., 1971; Webb et al., 1975) . Concomitant increases in gammaglutamyl, transpeptidase and leucine amino-peptidase levels suggest that the alkaline phosphatase may have been of hepatic rather than bone origin. Histological abnormalities on liver biopsy have been found in 25% to 500% of rheumatoid patients (Lefkovits and Farrow, 1955; Webb et al., 1975; Dietrichson et al., 1976) , the most frequent change, apart from fatty liver, being a mononuclear cell infiltration of the portal tracts suggestive of a biliary rather than an hepatocellular lesion.
The mechanisms underlying the development of these liver abnormalities are unknown, though the hepatotoxic properties of some of the drugs used in treatment may be a factor. However, the sicca syndrome (manifest as xerostomia and xerophthalmia) is a common systemic manifestation both of rheumatoid arthritis (Bioch et al., 1965) and of the 'autoimmune' liver diseases, chronic active hepatitis and primary biliary cirrhosis (Golding et al., 1970 (Sullivan et al., 1978) . Total saliva flow was measured by spitting into a beaker all saliva produced during 10 minutes while chewing mint-flavoured gum. Xerostomia was diagnosed in patients who produced lexs than 12 ml, which was 2 standard deviations below the mean obtained in 20 normal subjects under identical conditions (Sullivan et al., 1978) .
Laboratory investigations included a blood count and erythrocyte sedimentation rate. Rheumatoid factor was estimated by latex agglutination. Antinuclear, antismooth muscle, and antimitochondrial antibodies were detected by immunofluorescence and hepatitis B virus surface antigen and antibody by radioimmunoassay (AUSRIA II, Abbot Laboratories). In addition to serum albumin and globulin concentration, biochemical evaluation of liver function included total bilirubin, aspartate aminotransferase, total alkaline phosphatase, and gammaglutamyl transpeptidase. In 50 unselected patients alkaline phosphatase isoenzymes were determined by polyacrylamide gel electrophoresis (Warnes et al., 1976) by one of us (T.W.), who was unaware of the clinical and biochemical findings at the time.
Results
In the 100 patients (mean age 58 10 years) the mean duration of arthritis was 11 + 10 years. The mean grip strength and articular index were 103 + 68 mmHg and 9 ± 5 respectively, and the mean duration of morning stiffness was 42 ± 40 minutes. There were no significant differences between males and females in these parameters. None of the patients had hepatomegaly, splenomegaly, or any cutaneous stigmata of liver disease. In no patient was Hb-Ag detectable but 15 % had Hb,Ab-an incidence similar to that reported for a control population (Reed et al., 1974) .
LIVER FUNCTION TESTS
Total bilirubin was normal in all patients. Serum albumin was low in 5, ranging from 29 to 34 g/l (lower normal limit, 35 g/l), while 2 others had marginal elevations of aspartate aminotransferase of 54 and 59 IU/l (upper normal limit, 50 IU/l). Thirty-five patients had a total serum alkaline phosphatase (ALP) in excess of 100 IU/l, and 19 had a raised gammaglutamyl transpeptidase (GGT). There were no statistical associations between elevations in serum ALP and the patients' sex, duration, or severity of arthritis, drug or alcohol history. Patients with raised serum ALP had a higher median age (63.5 years) than those with normal ALP levels (59 years), but this difference was not statistically significant. Raised total serum ALP was found in 2 of 3 patients with a past history of jaundice and in 2 of 3 others who had had cholecystectomies.
SALIVARY AND LACRIMAL GLAND FUNCTION
Fifty-eight patients had objective evidence of impaired lacrimal or salivary secretion, 26 with xerophthalmia, 18 with xerostomia, and 15 with both. There were no apparent clinical differences between those with and without impaired secretion. However, 27 of the 58 had elevated serum levels of ALP-a significantly (P<0.01) higher incidence than that (8 out of 42) observed in patients with apparently normal salivary and lacrimal gland function. Furthermore, as a group, patients with xerostomia and/or xerophthalmia had significantly higher ALP levels than those without either of these features (Table 1) . A similar trend was noted for GGT, raised levels of this enzyme being found in 15 of the Fifteen of the 50 patients whose sera were examined for ALP isoenzymes had an elevated total ALP ( Table 2 ). Nine of these had the, liver isoenzyme as the sole component of the main-electrophoretic band position, while the remaining 6 had both liver and bone isoenzymes but with the liver band markedly stronger in each case, suggesting that the elevations in total ALP were due to increases in the liver isoenzyme. Three of the 15 also had a band which remained at the site of application-the socalled 'origin band', which so far has been found only in patients with liver disease (Warnes et al., 1976) . Of the 35 patients with normal ALP levels 13 had the liver isoenzyme as the sole component of the main band position. The remaining 22 all showed both liver and bone isoenzymes, but in 16 (73%) the liver component was stronger. In 4 (18 %) the two isoenzymes were of approximately equal strength, while in 2 the bone component was stronger.
Intestinal ALP was found as frequently in patients with raised ALP (6 out of 15) as in those with normal enzyme levels (17 out of 35)-an incidence which is similar to that found in normal subjects (Warnes et al., 1977) .
Nine of the 15 patients with raised liver ALP had concomitant elevations in serum GGT. By comparison only 3 of the 35 with normal ALP levels had an elevated GGT (P<0 0005), and 1 of these (patient 31, Table 2 ) was the only patient receiving barbiturates for night sedation at the time of study.
Discussion
In the present study biochemical evidence of liver disease (consisting mainly of elevations in serum ALP and/or GGT) was found in 45% of the 100 patients with rheumatoid arthritis. In skeletal disorders elevations in serum ALP are often considered to be due to increased levels of the bone isoenzyme. It is of interest, therefore, that only 2 (4%) of the 50 patients whose sera were studied had the bone isoenzyme as the dominant electrophoretic band. Indeed the liver isoenzyme was the sole or major component even in those with normal total ALP levels. This is in contrast to our findings in normal subjects, in only 32 % of whom the liver isoenzyme was predominant, and never as the sole component (Warnes, 1972; Warnes et al., 1976) .
Increases in serum GGT levels are more particularly associated with disease of the liver and especially with disorders involving the biliary tract (Lum and Gambino, 1972) . Enzyme-inducing agents, including barbiturates, can produce elevations in GGT (Rosalki et al., 1971) , but this applied to only I of our patients, who did have a very high serum level of this enzyme-without a concomitant elevation in ALP. In the 9 patients (representing 18% of the series) who had both raised GGT and liver ALP subclinical liver disease would seem to be a real possibility. (Anderson, 1975) . Moreover, with the exception of the 1 patient with antimitochondrial antibody, the presence of these immunological markers of chronic liver disease did not correlate with increased levels of the liver enzymes nor with lacrimal or salivary gland dysfunction.
The finding that most patients with xerostomia and/or xerophthalmia had significantly higher ALP levels than those without is in agreement with observations of other workers (Webb et al., 1975) and is of interest in the context of other known interrelationships between joint disease and liver disease. A number of rheumatic disorders are included in the spectrum of multisystem involvement which is a characteristic feature of chronic active hepatitis (CAH) and primary biliary cirrhosis (PBC). Arthropathies occur in up to 27% of CAH and in 5-10% of PBC patients (Golding et al., 1973) , and scleroderma has been reported in 17 % of those with PBC (Clarke et al., 1978) . Both rheumatoid arthritis (as Sjogren's syndrome) and scleroderma (Alarcon-Segovia et al., 1974) are frequently associated with the sicca syndrome, which also occurs in 75-100% of patients with PBC (Alarcon-Segovia et al., 1973; McFarlane et al., 1976) . Some of these systemic manifestations might be related to the presence of circulating immune complexes, which have been reported particularly in the sera of PBC patients (Wands et al., 1978) . Immune complexes are also found in rheumatoid arthritis and could account for the portal tract mononuclear cell infiltration observed in liver biopsies from rheumatoid patients (Lefkovits and Farrow, 1955; Webb et al., 1975; Dietrichson et al., 1976) . In our patients, however, the biochemical evidence was more suggestive of bile duct damage, and it has been shown experimentally that injection of immune complexes into the systemic circulation does not lead to bile duct damage (Paronetto et al., 1962) .
A more likely hypothesis, for which we have obtained some evidence, is that immunologically mediated damage to structures in one organ (as occurs in the livers of patients with CAH or PBC) leads to sensitisation to a number of self-antigens, Studies on the frequency andpathogenesis of liver involvmenet in rheumatoid arthritis 505 some of which cross-react with antigens in other tissues in which similar immunologically mediated disease processes may consequently be initiated (Tsantoulas et al., 1974a; McFarlane et al., 1976) . Approximately 80% of PBC patients show in-vitro leucocyte migration inhibition in response to biliary antigens (Eddleston et al., 1973; Tsantoulas et al., 1974b; McFarlane et al., in press) . We have also shown that patients with sicca syndrome secondary to either rheumatoid arthritis or primary biliary cirrhosis show cellular immune responses to salivary antigens which cross-react immunologically with antigens present in the normal human biliary tract (McFarlane et al., 1976; Sullivan et al., 1978; Wojcicka, 1979) . In the present study there appeared to be an association between the presence of the sicca syndrome and raised serum levels of liver enzymes, and it is possible that the development of hepatobiliary lesions in rheumatoid arthritis might be related to immune responses to crossreacting salivary and biliary antigens. Further studies will be required to determine whether cellular immune responses to biliary antigens (similar to those demonstrated in PBC) are to be found in patients with rheumatoid arthritis. 
